Correlation Between Janux Therapeutics and Opthea

Can any of the company-specific risk be diversified away by investing in both Janux Therapeutics and Opthea at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Janux Therapeutics and Opthea into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Janux Therapeutics and Opthea, you can compare the effects of market volatilities on Janux Therapeutics and Opthea and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Janux Therapeutics with a short position of Opthea. Check out your portfolio center. Please also check ongoing floating volatility patterns of Janux Therapeutics and Opthea.

Diversification Opportunities for Janux Therapeutics and Opthea

-0.05

Correlation Coefficient

Janux Therapeutics  Opthea

Good diversification

The 3 months correlation between Janux and Opthea is -0.05. Overlapping area represents the amount of risk that can be diversified away by holding Janux Therapeutics and Opthea in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Opthea and Janux Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Janux Therapeutics are associated (or correlated) with Opthea. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Opthea has no effect on the direction of Janux Therapeutics i.e., Janux Therapeutics and Opthea go up and down completely randomly.

Pair Corralation between Janux Therapeutics and Opthea

Given the investment horizon of 90 days Janux Therapeutics is expected to generate 1.56 times more return on investment than Opthea. However, Janux Therapeutics is 1.56 times more volatile than Opthea. It trades about 0.07 of its potential returns per unit of risk. Opthea is currently generating about 0.04 per unit of risk. If you would invest  5,001  in Janux Therapeutics on September 13, 2024 and sell it today you would earn a total of  1,149  from holding Janux Therapeutics or generate 22.98% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Janux Therapeutics  vs.  Opthea

Janux Therapeutics

Risk-Adjusted Performance

5 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Janux Therapeutics are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of fairly uncertain basic indicators, Janux Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.

Opthea

Risk-Adjusted Performance

3 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Opthea are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unfluctuating basic indicators, Opthea may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Pair Trading with Janux Therapeutics and Opthea

The main advantage of trading using opposite Janux Therapeutics and Opthea positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Janux Therapeutics position performs unexpectedly, Opthea can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Opthea will offset losses from the drop in Opthea's long position.

The idea behind Janux Therapeutics and Opthea pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..